Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Atopic eczema: genetics or environment?

Brunello Wüthrich1, Antonio Cozzio, Antonie Roll

  • 1Spital Zollikerberg, Allergologie, klinische Immunologie und Dermatologie, Trichtenhauserstrasse 20, 8125 Zollikerberg, Switzerland. bs.wuethrich@bluewin.ch

Annals of Agricultural and Environmental Medicine : AAEM
|February 6, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Update of the evidence- and consensus-based S3 guideline on atopic dermatitis: Systemic therapy with biologics or Janus kinase inhibitors and specific aspects of systemic therapy in pregnancy and lactation.

Allergologie select·2026
Same author

Swiss Practice Recommendations for Chronic Prurigo Including Prurigo Nodularis.

International journal of dermatology·2026
Same author

Self-Assembled Skin Equivalents with Monoclonal CRISPR/Cas9-Modified N/TERT-1 Keratinocytes: A Cutting-Edge Model for Human Skin and its Diseases.

Advanced healthcare materials·2026
Same author

NLRP1 inflammasome activation in skin equivalents reveals mechanistic insights into the roles of keratinocytes in psoriasis.

Cell death & disease·2026
Same author

[Retrospective analysis of epidemiology, clinical characteristics and management of 300 Scabies cases].

Praxis·2026
Same author

Noninvasive Imaging Modalities for Evaluating Patch Testing: A Systematic Review.

Dermatitis : contact, atopic, occupational, drug·2026
Same journal

Atypical eczema-like skin symptoms and joint swelling in a patient with Toxocara seropositivity - Case Report.

Annals of agricultural and environmental medicine : AAEM·2026
Same journal

Family medicine in rural and depopulating recommendations in the light of the professional preferences of young physicians.

Annals of agricultural and environmental medicine : AAEM·2026
Same journal

The cytoprotective role of whey protein hydrolysates against CdCl<sub>2</sub>-induced toxicity in fibroblasts by the Electric Cell-substrate Impedance Sensing (ECIS) method.

Annals of agricultural and environmental medicine : AAEM·2026
Same journal

An evaluation of a physical therapy app for home rehabilitation.

Annals of agricultural and environmental medicine : AAEM·2026
Same journal

Self-assessment of health status and identification of traffic hazards for urban cyclists.

Annals of agricultural and environmental medicine : AAEM·2026
Same journal

Evaluation of relationship between type of body shape assessed using waist-to-hip ratio, and occurrence of cardiovascular risk factors in patients with acute coronary syndrome.

Annals of agricultural and environmental medicine : AAEM·2026
See all related articles

Filaggrin gene mutations are a major cause of atopic eczema, leading to skin barrier defects and increased risk of infections and the atopy march. Therapies like topical immunomodulators offer improved treatment options.

Area of Science:

  • Dermatology
  • Genetics
  • Immunology

Background:

  • Atopic eczema (AE) is a complex skin condition influenced by genetics, skin structure, immunity, and environment.
  • Filaggrin (FL), a key protein in skin structure, is implicated in AE pathogenesis.
  • FLG mutations are prevalent in moderate to severe AE and linked to the "atopy march".

Purpose of the Study:

  • To explore the role of Filaggrin (FL) in atopic eczema (AE).
  • To understand how FLG mutations impact skin barrier function and susceptibility to infections.
  • To review current therapeutic strategies for AE.

Main Methods:

  • Review of genetic studies identifying Filaggrin (FL) mutations in atopic eczema (AE).
  • Analysis of the functional consequences of FLG mutations on skin barrier integrity.

Related Experiment Videos

  • Examination of the association between FLG mutations and microbial colonization.
  • Review of immunological mechanisms driving AE inflammation.
  • Assessment of therapeutic interventions for AE.

    • Main Results:

    • Filaggrin (FL) mutations are a significant genetic factor in atopic eczema (AE), found in over half of affected children.
    • Loss-of-function FLG mutations impair skin barrier function, increasing susceptibility to Staphylococcus aureus and yeast colonization.
    • AE pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental triggers.
    • Current treatments, including emollients, corticosteroids, and topical immunomodulators, have improved AE management.

    Conclusions:

    • Filaggrin (FL) mutations are a critical determinant in the development and severity of atopic eczema (AE).
    • Understanding the role of FLG mutations provides insights into AE pathophysiology and the "atopy march".
    • Advanced therapies like topical immunomodulators offer significant benefits for AE patients.